Cerus | CERS - Sales Revenues

Stock Price
2.04
Daily Change
-0.21 -9.15%
Monthly
-7.50%
Yearly
33.01%
Q1 Forecast
2.48

Cerus reported $50.81M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Cerus USD 50.81M 4.79M Dec/2024
GRIFOLS EUR 1.98B 110M Dec/2025
Haemonetics USD 338.97M 11.97M Dec/2025
Neogen USD 224.69M 15.5M Sep/2025
OraSure Technologies USD 39.92M 14.42M Sep/2024
Plus Therapeutics USD 1.31M 73K Dec/2023
Quidel USD 724M 24M Dec/2025
Rockwell Medical USD 25.83M 3.15M Jun/2024
STAAR Surgical USD 239.4M 144.7M Dec/2025
Terumo JPY 296.63B 21.66B Dec/2025
Utah Medical Products USD 10M 400K Sep/2024